JP2022547604A5 - - Google Patents

Info

Publication number
JP2022547604A5
JP2022547604A5 JP2022516271A JP2022516271A JP2022547604A5 JP 2022547604 A5 JP2022547604 A5 JP 2022547604A5 JP 2022516271 A JP2022516271 A JP 2022516271A JP 2022516271 A JP2022516271 A JP 2022516271A JP 2022547604 A5 JP2022547604 A5 JP 2022547604A5
Authority
JP
Japan
Prior art keywords
use according
compound
approximately
sleepiness
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022516271A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022547604A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/058482 external-priority patent/WO2021048821A1/en
Publication of JP2022547604A publication Critical patent/JP2022547604A/ja
Publication of JP2022547604A5 publication Critical patent/JP2022547604A5/ja
Pending legal-status Critical Current

Links

JP2022516271A 2019-09-13 2020-09-12 過度の眠気の治療のためのオレキシン2受容体アゴニストの使用 Pending JP2022547604A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962900310P 2019-09-13 2019-09-13
US62/900,310 2019-09-13
US202063031687P 2020-05-29 2020-05-29
US63/031,687 2020-05-29
PCT/IB2020/058482 WO2021048821A1 (en) 2019-09-13 2020-09-12 Use of an orexin 2 receptor agonist for the treatment of excessive sleepiness

Publications (2)

Publication Number Publication Date
JP2022547604A JP2022547604A (ja) 2022-11-14
JP2022547604A5 true JP2022547604A5 (https=) 2023-09-20

Family

ID=72521681

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022516271A Pending JP2022547604A (ja) 2019-09-13 2020-09-12 過度の眠気の治療のためのオレキシン2受容体アゴニストの使用

Country Status (11)

Country Link
US (1) US20220331303A1 (https=)
EP (1) EP4028003A1 (https=)
JP (1) JP2022547604A (https=)
KR (1) KR20220062361A (https=)
CN (1) CN114555083A (https=)
AU (1) AU2020347578A1 (https=)
BR (1) BR112022004576A2 (https=)
CA (1) CA3154320A1 (https=)
CO (1) CO2022004589A2 (https=)
MX (1) MX2022003017A (https=)
WO (1) WO2021048821A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI4065585T3 (fi) 2019-11-25 2025-09-26 Alkermes Inc Substituoituja makrosyklisiä yhdisteitä ja niihin liittyviä hoitomenetelmiä
MX2022008392A (es) 2020-01-10 2022-08-08 Takeda Pharmaceuticals Co Metodo para mejorar la farmacocinetica o aumentar la concentracion de plasma de 3-((metilsulfonil)amino)-2-(((4-fenilci clohexil)oxi)metil)piperidina-1-carboxilato de metilo o una sal del mismo con un inhibidor de citocromo p450.
US12503475B2 (en) 2020-09-03 2025-12-23 Centessa Pharmaceuticals (Uk) Limited Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment
US12006330B2 (en) 2020-12-21 2024-06-11 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
AR130709A1 (es) 2022-10-07 2025-01-08 Kissei Pharmaceutical Compuesto de ciclopentano
TW202502342A (zh) * 2023-06-02 2025-01-16 日商武田藥品工業股份有限公司 食慾素2受體促效劑用於改善睡眠期間之呼吸功能的用途
WO2025124698A1 (en) 2023-12-12 2025-06-19 Idorsia Pharmaceuticals Ltd Aryl sulfone and sulfanone derivatives as orexin receptor modulators
TW202542165A (zh) 2023-12-19 2025-11-01 瑞士商愛杜西亞製藥有限公司 大環食慾素激動劑

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854204A (en) 1995-03-14 1998-12-29 Praecis Pharmaceuticals, Inc. Aβ peptides that modulate β-amyloid aggregation
JP2001500852A (ja) 1996-08-27 2001-01-23 プレーシス ファーマスーティカルズ インコーポレイテッド D―アミノ酸を含むβ―アミロイドペプチド凝集のモジュレーター
CA2374610A1 (en) 1999-06-28 2001-01-04 Jordan J. N. Tang Catalytically active recombinant memapsin and methods of use thereof
PL3411358T3 (pl) * 2016-02-04 2022-02-28 Takeda Pharmaceutical Company Limited Podstawiony związek piperydynowy i jego zastosowanie
JOP20190008A1 (ar) * 2016-07-26 2019-01-24 Purdue Pharma Lp علاج ومنع اضطرابات النوم
CA3154321A1 (en) * 2019-09-13 2021-03-18 Takeda Pharmaceutical Company Limited Tak-925 for use in treating narcolepsy

Similar Documents

Publication Publication Date Title
JP2022547604A5 (https=)
JP7373997B2 (ja) 睡眠時無呼吸を治療する方法及び組成物
JP2022547711A5 (https=)
US20240390299A1 (en) Methods and compositions for treating sleep apnea
Stepnowsky Jr et al. Nasal CPAP treatment for obstructive sleep apnea: developing a new perspective on dosing strategies and compliance
JP2022547711A (ja) ナルコレプシーの治療に使用するためのtak-925
HU216731B (hu) Modafinil alkalmazása alvási apnoe és központi eredetű légzészavarok kezelésére szolgáló gyógyászati készítmény előállítására
JP2022547604A (ja) 過度の眠気の治療のためのオレキシン2受容体アゴニストの使用
JP7705348B2 (ja) 睡眠時無呼吸を治療するための方法および組成物
US20080261931A1 (en) Method and Means of Preventing and Treating Sleep Disordered Breathing
JP2014503593A (ja) 閉塞性睡眠時無呼吸を処置するための方法
JP2024088740A (ja) 睡眠時無呼吸を治療するための方法及び組成物
AU2005212149B2 (en) Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
EP4719397A1 (en) Use of an orexin 2 receptor agonist for improving respiratory function during sleep
Singh et al. A comparative study of two different doses of dexmedetomedine as an adjuvant to lignocaine in infiltration block for tympanoplasty: a triple-blinded, prospective, randomized controlled trial
HK40117857A (en) Methods and compositions for treating sleep apnea
EA047115B1 (ru) Способы и композиции для лечения апноэ сна
HK40013951A (en) Methods and compositions for treating sleep apnea